The July issue of CKJ is out!
MUST READ
Dapagliflozin treatment in patients with chronic kidney disease associated with autosomal dominant polycystic kidney disease
In CKD patients with ADPKD, dapagliflozin may increase kidney volume but may have a protective effect on kidney function when used concomitantly with RAS inhibitors.
EDITOR’S CHOICE FROM JULY ISSUE
Pro/con debate on physical exercise in haemodialysis patients: which type of exercise is more convenient?
Find out here the advantages and disadvantages of intra-haemodialysis and home-based exercise in haemodialysis patients.